| Literature DB >> 32617115 |
JiaJia Ye1,2,3, Qikai Zheng4, Liye Zou5, Qian Yu5, Nicola Veronese6, Igor Grabovac7, Sinisa Stefanac7, Huey-Ming Tzeng8, Jane Jie Yu9.
Abstract
BACKGROUND: The postural stability is a major factor that helps prevent developing knee osteoarthritis with aging. The aim of this study was to investigate the effects of Baduanjin qigong on postural control and physical function in older adults with knee osteoarthritis.Entities:
Year: 2020 PMID: 32617115 PMCID: PMC7312696 DOI: 10.1155/2020/9869161
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Postural control measurement on ProKin system.
Baseline characteristics of participants.
| Characteristics | BD ( | CG ( |
|
|---|---|---|---|
| Gender ( | |||
| Male | 11 | 8 | |
| Female | 17 | 20 | 0.678 |
| Age (year) | 65.11 ± 6.57 | 63.61 ± 2.63 | 0.237 |
| Height (cm) | 164.04 ± 7.73 | 163.32 ± 8.27 | 0.740 |
| Weight (kg) | 65.32 ± 8.97 | 65.61 ± 7.09 | 0.895 |
| Body mass index (kg/m2) | 24.19 ± 2.37 | 24.63 ± 2.27 | 0.439 |
BD, Baduanjin group; CG, control group.
Figure 2The detailed procedure of this study.
Comparison of postural stability and WOMAC function between the BD and control groups over time.
| Variable | BD | CG | MD |
| Time effect | Group × time effect | ||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| OP perimeter (mm) | 0.176 | 0.180 | 1.756 | 0.031 | ||||
| Baseline | 379.86 ± 272.80 | 364.32 ± 190.45 | 15.54 | 0.806 (−110.52∼141.59) | ||||
| Week 8 | 367.07 ± 199.36 | 381.50 ± 196.21 | −14.43 | 0.786 (−120.14∼91.55) | ||||
| Week 12 | 252.64 ± 129.22 | 346.71 ± 393.78 | −94.07 | 0.235 (251.10∼62.96) | ||||
| OP ellipse area (mm2) | 0.001 | 0.001 | 19.730 | 0.268 | ||||
| Baseline | 799.96 ± 334.53 | 860.07 ± 223.79 | −60.11 | 0.433 (−212.60∼92.39) | ||||
| Week 8 | 704.46 ± 295.06 | 774.36 ± 134.91 | −69.90 | 0.259 (−192.82∼53.03) | ||||
| Week 12 | 391.93 ± 260.39 | 627.57 ± 358.06 | −235.64 | 0.007 | ||||
| CP perimeter (mm) | 0.003 | 0.005 | 5.993 | |||||
| Baseline | 532.39 ± 2252.33 | 509.36 ± 192.20 | 23.03 | 0.702 (−97.14∼143.22) | ||||
| Week 8 | 553.50 ± 201.31 | 508.86 ± 243.19 | 44.64 | 0.458 (−74.97∼164.26) | ||||
| Week 12 | 450.14 ± 215.22 | 346.71 ± 393.78 | 103.43 | 0.564 (−76.71∼139.28) | ||||
| CP ellipse area (mm2) | 0.001 | 0.001 | 17.879 | 0.249 | ||||
| Baseline | 1248.11 ± 389.57 | 1147.29 ± 555.52 | 100.82 | 0.435 (−156.25∼357.90) | ||||
| Week 8 | 1057.43 ± 384.26 | 1026.14 ± 322.56 | 31.29 | 0.743 (−158.80∼221.37) | ||||
| Week 12 | 694.61 ± 305.31 | 820.93 ± 419.04 | −126.32 | 0.203 (−322.76∼70.12) | ||||
| WOMAC | 0.001 | 0.001 | 15.922 | 0.228 | ||||
| Baseline | 30.57 ± 11.88 | 28.21 ± 11.18 | 2.36 | 0.448 (−3.82∼8.54) | ||||
| Week 8 | 19.39 ± 9.60 | 28.39 ± 11.57 | −9.00 | 0.003 | ||||
| Week 12 | 15.32 ± 6.56 | 28.29 ± 7.96 | −12.97 | 0.001 | ||||
| Pain | 0.009 | 0.015 | 4.957 | 0.084 | ||||
| Baseline | 6.21 ± 2.67 | 7.36 ± 8.89 | −1.15 | 0.517 (−4.66∼2.37) | ||||
| Week 8 | 3.04 ± 1.53 | 6.21 ± 2.41 | −3.17 | 0.001 | ||||
| Week 12 | 3.79 ± 5.83 | 4.64 ± 1.91 | −0.85 | 0.463 (−3.18∼1.47) | ||||
| Stiffness | 0.531 | 0.399 | 0.927 | 0.017 | ||||
| Baseline | 4.04 ± 2.05 | 4.25 ± 1.38 | −0.21 | 0.648 (−1.15∼0.72) | ||||
| Week 8 | 2.36 ± 1.64 | 6.79 ± 2.56 | −4.43 | 0.001 | ||||
| Week 12 | 2.46 ± 1.58 | 6.29 ± 2.11 | −3.83 | 0.001 | ||||
| Physical function | 0.001 | 0.001 | 14.302 | 0.209 | ||||
| Baseline | 20.36 ± 10.52 | 18.25 ± 8.04 | 2.11 | 0.409 (−2.98∼7.19) | ||||
| Week 8 | 14.43 ± 9.10 | 15.68 ± 9.09 | −1.25 | 0.609 (−6.122∼3.622) | ||||
| Week 12 | 9.96 ± 5.95 | 16.00 ± 6.54 | −6.04 | 0.001 | ||||
OP, open-eyes; CP, closed-eyes; BD, Baduanjin group; CG, control group; WOMAC, the Western Ontario and Mcmaster Universities Osteoarthritis Index; MD, mean change. Significant effect (p < 0.05).
Comparison of postural stability and WOMAC function over time in both groups.
| Variable | Week 0 vs. week 8 | Week 8 vs. week 12 | Week 0 vs. week 12 | |
|---|---|---|---|---|
| BD | ||||
| OP |
| 0.828 | 0.013 | 0.018 |
| Perimeter (mm) | 95% CI | −106.86 to 132.43 | 26.56 to 202.29 | 23.13 to 231.31 |
| OP |
| 0.226 | 0.001 | 0.001 |
| Ellipse area (mm2) | 95% CI | −62.78 to 253.78 | 161.29 to 463.78 | 223.94 to 592.13 |
| CP |
| 0.693 | 0.001 | 0.052 |
| Perimeter (mm) | 95% CI | −129.46 to 87.24 | 26.87 to 179.85 | −0.67 to 165.17 |
| CP |
| 0.064 | 0.001 | 0.001 |
| Ellipse area (mm2) | 95% CI | −12.05 to 393.41 | 474.27 to 856.73 | 391.38 to 715.62 |
| WOMAC |
| 0.001 | 0.049 | 0.001 |
| 95% CI | 7.26 to 15.30 | 0.01 to 8.13 | 11.60 to 18.90 | |
| Pain |
| 0.001 | 0.515 | 0.05 |
| 95% CI | 2.06 to 4.30 | −3.08 to 1.58 | −0.06 to 4.92 | |
| Stiffness |
| 0.001 | 0.769 | 0.001 |
| 95% CI | 0.72 to 2.64 | −8.5 to 0.63 | 0.71 to 2.43 | |
| Physical function |
| 0.003 | 0.024 | 0.001 |
| 95% CI | 2.25 to 9.61 | 0.62 to 8.31 | 7.44 to 13.35 | |
| CG | ||||
| OP |
| 0.744 | 0.674 | 0.839 |
| Perimeter (mm) | 95% CI | −124.00 to 89.64 | −133.29 to 202.86 | −159.05 to 194.26 |
| OP |
| 0.068 | 0.033 | 0.012 |
| Ellipse area (mm2) | 95% CI | −6.72 to 178.15 | 12.72 to 280.85 | 55.75 to 409.25 |
| CP |
| 0.992 | 0.037 | 0.020 |
| Perimeter (mm) | 95% CI | −101.26 to 102.26 | 5.73 to 174.27 | 15.609 to 165.39 |
| CP |
| 0.357 | 0.001 | 0.014 |
| Ellipse area (mm2) | 95% CI | −143.86 to 386.14 | 206.08 to 591.07 | 70.88 to 581.84 |
| WOMAC |
| 0.935 | 0.944 | 0.975 |
| 95% CI | −4.64 to 4.28 | −3.01 to 3.22 | −4.67 to 4.53 | |
| Pain |
| 0.515 | 0.005 | 0.124 |
| 95% CI | −2.41 to 4.70 | 0.52 to 2.62 | −0.79 to 6.22 | |
| Stiffness |
| 0.001 | 0.372 | 0.001 |
| 95% CI | −3.47 to −0.61 | −0.63 to 1.63 | −2.84 to −1.23 | |
| Physical function |
| 0.159 | 0.825 | 0.235 |
| 95% CI | −1.07 to 6.21 | −3.30 to 2.63 | −1.55 to 6.05 | |
Significant effect (p < 0.005). OP, open-eyes; CP, closed-eyes; BD, Baduanjin group; CG, control group; WOMAC, the Western Ontario and Mcmaster Universities Osteoarthritis Index; week 0, pretest; week 8, 8th postassessment; week 12, 12th postassessment.